Mechanisms, biomarkers and targets for adult-onset Still’s disease

Complications of adult-onset Still’s disease and their management

(2018) Stéphane Mitrovic et al.   Expert Review of Clinical Immunology

New Markers for Adult-Onset Still's Disease

(2018) Stéphane Mitrovic et al.   JOINT BONE SPINE

Increased Severity and Epidermal Alterations in Persistent versus Evanescent Skin lesions in Adult Onset Still’s disease

(2018) Elina Zuelgaray et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still’s disease: A meta-analysis

(2018) Yubo Ma et al.   Modern Rheumatology

Validation of the Fautrel classification criteria for adult-onset Still’s disease

(2018) Delphine Lebrun et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Adult onset Still’s disease—The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review)

(2017) Guido Junge et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study

(2017) Serena Colafrancesco et al.   Frontiers in Pharmacology

Pulmonary arterial hypertension and acute respiratory distress syndrome in a patient with adult-onset stills disease

(2017) Grant H. Lowther et al.   Pulmonary Circulation

Adult-onset Still's disease: Advances in the treatment

(2016) Santos Castañeda et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

The burgeoning field of innate immune-mediated disease and autoinflammation

(2016) Daniel Peckham et al.   JOURNAL OF PATHOLOGY

C13orf31 (FAMIN) is a central regulator of immunometabolic function

(2016) M Zaeem Cader et al.   NATURE IMMUNOLOGY

Epidemiological study of adult-onset Still’s disease using a Japanese administrative database

(2016) Nobuo Sakata et al.   RHEUMATOLOGY INTERNATIONAL

Pulmonary arterial hypertension in adult onset Still’s disease: a case report of a severe complication

(2016) L. Guilleminault et al.   BMC Pulmonary Medicine

An Atypical Presentation of Adult-Onset Still's Disease Complicated by Pulmonary Hypertension and Macrophage Activation Syndrome Treated with Immunosuppression: A Case-based Review of the Literature

(2016) Mili V. Mehta et al.   Pulmonary Circulation

Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1β expression and release

(2015) S.R. Hofmann et al.   CLINICAL IMMUNOLOGY

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN RESPIRATORY JOURNAL

Efficacy of Anakinra in Refractory Adult-Onset Stillʼs Disease

(2015) Francisco Ortiz-Sanjuán et al.   MEDICINE

Management of hereditary recurrent fevers—SHARE experience

(2015) Guillaume Sarrabay et al.   Nature Reviews Rheumatology

Gene-expression analysis of adult-onset Still’s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity

(2015) Nanguneri Nirmala et al.   Pediatric Rheumatology

HLA-DRB1*11and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis

(2015) Michael J. Ombrello et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still’s disease

(2015) Jae Ho Han et al.   ARTHRITIS RESEARCH & THERAPY

Successful Treatment of Refractory Adult-Onset Still Disease With Canakinumab

(2015) Simone Barsotti et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Adult onset Still's disease (AOSD) in the era of biologic therapies: Dichotomous view for cytokine and clinical expressions

(2014) Alexandre Thibault Jacques Maria et al.   AUTOIMMUNITY REVIEWS

Adult-onset Still's disease

(2014) Mathieu Gerfaud-Valentin et al.   AUTOIMMUNITY REVIEWS

Immune Dysregulation and Endothelial Dysfunction in Pulmonary Arterial Hypertension

(2014) Alice Huertas et al.   CIRCULATION

Life-threatening complications of adult-onset Still’s disease

(2014) Petros Efthimiou et al.   CLINICAL RHEUMATOLOGY

sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia

(2014) S. Colafrancesco et al.   IMMUNOLOGIC RESEARCH

Pathogenesis of adult-onset Still’s disease: new insights from the juvenile counterpart

(2014) Yvan Jamilloux et al.   IMMUNOLOGIC RESEARCH

Steroid-sparing Effects of Etanercept in a Patient with Steroid-dependent Adult-onset Still's Disease

(2014) Yasuhiro Kiyonaga et al.   INTERNAL MEDICINE

A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6

(2014) Sabeeda Kadavath et al.   International Journal of Rheumatic Diseases

Canakinumab in a case of Adult onset Still's disease: Efficacy only on systemic manifestations

(2014) Alberto Lo Gullo et al.   JOINT BONE SPINE

Interleukin 18: A Biomarker for Differential Diagnosis Between Adult-onset Still's Disease and Sepsis

(2014) R. Priori et al.   JOURNAL OF RHEUMATOLOGY

Serum S100A12 May Be a Useful Biomarker of Disease Activity in Adult-onset Still's Disease

(2014) C.-B. Bae et al.   JOURNAL OF RHEUMATOLOGY

Tocilizumab in Adult-onset Still's Disease: the Israeli Experience

(2014) O. Elkayam et al.   JOURNAL OF RHEUMATOLOGY

Adult-Onset Still Disease

(2014) Mathieu Gerfaud-Valentin et al.   MEDICINE

A case of adult-onset Still’s disease complicated by thrombotic thrombocytopenic purpura with retinal microangiopathy and rapidly fatal cerebral edema

(2014) Atsushi Masuyama et al.   Modern Rheumatology

The effect of tocilizumab on preventing relapses in adult-onset Still's disease: A retrospective, single-center study

(2014) Naoshi Nishina et al.   Modern Rheumatology

Pro-resolving lipid mediators are leads for resolution physiology

(2014) Charles N. Serhan   NATURE

Clinical Characteristics and Treatment Outcomes of Autoimmune-Associated Hemophagocytic Syndrome in Adults

(2014) Shunichi Kumakura et al.   Arthritis & Rheumatology

Efficacy of Tocilizumab in Conventional Treatment-Refractory Adult-Onset Still's Disease: Multicenter Retrospective Open-Label Study of Thirty-Four Patients

(2014) Francisco Ortiz-Sanjuán et al.   Arthritis & Rheumatology

Association of a Mutation inLACC1With a Monogenic Form of Systemic Juvenile Idiopathic Arthritis

(2014) Salma M. Wakil et al.   Arthritis & Rheumatology

Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome

(2014) Laurence Fardet et al.   Arthritis & Rheumatology

The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome

(2013) Cristina Rosário et al.   BMC Medicine

Tocilizumab for the treatment of adult-onset Still’s disease: results from a case series

(2013) Paola Cipriani et al.   CLINICAL RHEUMATOLOGY

Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease

(2013) Christopher Banse et al.   JOINT BONE SPINE

Inheritance of autoinflammatory diseases: shifting paradigms and nomenclature

(2013) Isabelle Touitou   JOURNAL OF MEDICAL GENETICS

How should we approach classification of autoinflammatory diseases?

(2013) Gilles Grateau et al.   Nature Reviews Rheumatology

Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still’s disease

(2013) K-H Jung et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Clinical Manifestations of Adult-Onset Still's Disease Presenting With Erosive Arthritis: Association With Low Levels of Ferritin and Interleukin-18

(2013) Hisae Ichida et al.   ARTHRITIS CARE & RESEARCH

IL-1 Trap rilonacept in refractory adult onset Still's disease

(2012) Olga Petryna et al.   ANNALS OF THE RHEUMATIC DISEASES

Refractory Adult-Onset Still Disease Successfully Treated With Abatacept

(2012) Rochella A. Ostrowski et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Serum S100A8/A9, But Not Follistatin-like Protein 1 and Interleukin 18, May Be a Useful Biomarker of Disease Activity in Adult-onset Still’s Disease

(2012) HYOUN-AH KIM et al.   JOURNAL OF RHEUMATOLOGY

The Use of Canakinumab, a Novel IL-1β Long-Acting Inhibitor, in Refractory Adult-Onset Still's Disease

(2012) Apostolos Kontzias et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Anakinra in Adult-Onset Still's Disease: Long-Term Treatment in Patients Resistant to Conventional Therapy

(2012) Cecilia Giampietro et al.   ARTHRITIS CARE & RESEARCH

Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions

(2011) Elizabeth D. Mellins et al.   Nature Reviews Rheumatology

Pro-resolution immunological networks: binding immunoglobulin protein and other resolution-associated molecular patterns

(2011) A. M. Shields et al.   RHEUMATOLOGY

Treatment of refractory adult-onset still’s disease with tocilizumab: report of two cases and review of the literature

(2011) Rene Thonhofer et al.   RHEUMATOLOGY INTERNATIONAL

Soluble CD163

(2011) Holger J. Møller   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

The Evolution of Adult-Onset Still Disease: An Observational and Comparative Study in a Cohort of 76 Italian Patients

(2011) Matteo Colina et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease

(2010) L Naumann et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease

(2010) Stefano Franchini et al.   ARTHRITIS AND RHEUMATISM

Exacerbation of adult-onset Still’s disease, possibly related to elevation of serum tumor necrosis factor-alpha after etanercept administration

(2010) Kaichi KANEKO et al.   International Journal of Rheumatic Diseases

Clinical Manifestations but not Cytokine Profiles Differentiate Adult-onset Still's Disease and Sepsis

(2010) M. RAU et al.   JOURNAL OF RHEUMATOLOGY

Cytokine Profiles of Macrophage Activation Syndrome Associated with Rheumatic Diseases

(2010) J. MARUYAMA et al.   JOURNAL OF RHEUMATOLOGY

Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis

(2010) R. Priori et al.   RHEUMATOLOGY

Tocilizumab in refractory adult Still's disease

(2010) Xavier Puéchal et al.   ARTHRITIS CARE & RESEARCH

Thrombotic Thrombocytopenic Purpura and Adult Onset Still’s Disease

(2009) Muralikrishna Gopal et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Lymph node IL-18 expression in adult-onset Still's disease

(2009) P Conigliaro et al.   ANNALS OF THE RHEUMATIC DISEASES

Thrombotic microangiopathy and Purtscher-like retinopathy associated with adult-onset Still's disease: A role for glomerular vascular endothelial growth factor?

(2009) Khalil El Karoui et al.   ARTHRITIS AND RHEUMATISM

Systemic JIA: new developments in the understanding of the pathophysiology and therapy

(2009) Sebastiaan J. Vastert et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

(2009) et al.   CIRCULATION

Pulmonary arterial hypertension complicating adult-onset Still’s disease

(2009) Manisha Thakare et al.   CLINICAL RHEUMATOLOGY

Glucocorticoid and cyclosporine refractory adult onset Still’s disease successfully treated with tocilizumab

(2009) Kazuko Matsumoto et al.   CLINICAL RHEUMATOLOGY

S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin

(2008) Helmut Wittkowski et al.   ARTHRITIS AND RHEUMATISM

Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndrome

(2008) Laurence Fardet et al.   ARTHRITIS AND RHEUMATISM

Adult-onset Still disease

(2008) Bruno Fautrel   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease

(2008) Yu-Qiong Zou et al.   CLINICAL BIOCHEMISTRY

Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells

(2008) Richard G. Ruddell et al.   HEPATOLOGY

Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation

(2008) Matteo Colina et al.   RHEUMATOLOGY INTERNATIONAL

Primer: inflammasomes and interleukin 1β in inflammatory disorders

(2008) Leigh D Church et al.   Nature clinical practice. Rheumatology